Diabetes News and Research

Latest Diabetes News and Research

Study establishes critical roles for cancer-causing Myc gene in stem cell biology

Stem cells might be thought of as trunks in the tree of life. All multi-cellular organisms have them, and they can turn into a dazzling variety other cells-kidney, brain, heart or skin, for example. One class, pluripotent stem cells, has the capacity to turn into virtually any cell type in the body, making them a focal point in the development of cell therapies, the conquering of age-old diseases or even regrowing defective body parts.

3 Sep 2010

ASIPP announces educational campaign to improve chronic pain patients’ quality of life

In recognition of September's designation as National Pain Awareness Month, the American Society of Interventional Pain Physicians (ASIPP) today announced that it is planning a month-long educational campaign to improve the quality of life for the approximately 75 million Americans suffering from acute and chronic pain.

3 Sep 2010

Two scientists behind suit to block stem-cell research funding speak with lawmakers

The Wall Street Journal: "The two scientists behind the lawsuit that has temporarily blocked federal funding for embryonic stem-cell research said Wednesday they were motivated by ethical objections to destroying human embryos for medical research. The scientists, James Sherley of Boston and Theresa Deisher of Seattle, had never met until this week, when they flew to Washington to confer with House and Senate aides and lobby against research using embryonic stem cells.

3 Sep 2010

Fresh Market's 16th Annual Sidewalk Sale to benefit Juvenile Diabetes Research Foundation

The Fresh Market will hold its 16th annual "Hope Floats" Sidewalk Sale on September 10 through September 12, from 11:00 a.m. to 6:00 p.m. daily to benefit the Juvenile Diabetes Research Foundation (JDRF). The Fresh Market's stores, located in 20 states across the Southeast, Midwest, Mid-Atlantic and Northeast, will offer root beer floats, hot dogs, gourmet cookies and ice cream sundaes in exchange for a donation to JDRF in support of its mission to find a cure for diabetes and its complications.

3 Sep 2010

Research finds role of hormone-secreting fat cells in certain diseases

Scientists are reporting new evidence that the fat tissue in those spare tires and lower belly pooches far from being a dormant storage depot for surplus calories is an active organ that sends chemical signals to other parts of the body, perhaps increasing the risk of heart attacks, cancer, and other diseases.

3 Sep 2010

PCOS Challenge creates television series to help women with Polycystic Ovarian Syndrome

In an effort to bring greater awareness to Polycystic Ovarian Syndrome, PCOS Challenge, Inc. has created a 13-week television series to help women with PCOS. PCOS is estimated to affect one-in-ten women of childbearing age. It can lead to other serious conditions including endometrial cancer, obesity, diabetes and infertility.

3 Sep 2010

Study reveals factors linked to cognitive impairment in Type 2 diabetes

Older adults with diabetes who have high blood pressure, walk slowly or lose their balance, or believe they're in bad health, are significantly more likely to have weaker memory and slower, more rigid cognitive processing than those without these problems, according to a new study published by the American Psychological Association.

3 Sep 2010

Discovery of omega-3 fatty acid molecular mechanism paves way for development of dietary remedy for diabetes

Researchers at the University of California, San Diego School of Medicine have identified the molecular mechanism that makes omega-3 fatty acids so effective in reducing chronic inflammation and insulin resistance.

3 Sep 2010

European Commission approves MSD's MAA for SYCREST in manic episodes associated with bipolar I disorder

MSD announced today that the European Commission has approved the Marketing Authorization Application (MAA) for SYCREST® (asenapine) sublingual tablets for the treatment of moderate to severe manic episodes associated with bipolar I disorder in adults. Today's decision was based on recommendations from the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP). The Commission Decision applies to all 27 European Member States.

3 Sep 2010

Stem Cell Assurance announces $1M agreement with private funding source

Stem Cell Assurance, Inc., a leader in stem cell collection and storage services for personal applications ranging from breast augmentation and facial rejuvenation procedures to Stem Cellutrition skincare products, today announced a $1M agreement with a private funding source.

3 Sep 2010

Researchers find hair cortisol level can assess chronic stress in heart attack

Researchers at The University of Western Ontario have provided the first direct evidence using a biological marker, to show chronic stress plays an important role in heart attacks.

3 Sep 2010

NSU receives grant to improve geriatrics care

Nova Southeastern University recently received a $2.1-million federal grant to provide training to improve care for South Florida's large geriatric population now and for the future.

3 Sep 2010

Researchers unveil prototype model of first implantable artificial kidney

UCSF researchers today unveiled a prototype model of the first implantable artificial kidney, in a development that one day could eliminate the need for dialysis.

3 Sep 2010

Diabetes drug metformin exhibits potential against tobacco-induced lung tumors

Metformin, a drug commonly used to treat type 2 diabetes, shows potential in the prevention of tobacco-induced lung tumors, according to early research conducted at the National Cancer Institute (NCI).

3 Sep 2010

Greater Cincinnati receives award to improve health care system

U.S. Department of Health and Human Services Secretary Kathleen Sebelius announced today that the Greater Cincinnati community was awarded a $13.8 million Beacon Community cooperative agreement.

3 Sep 2010

CaPre drug candidate shows promising result on CRP level reduction

Acasti Pharma Inc., a subsidiary of Neptune Technologies & Bioressources Inc. reports significant results on the effects of its anti-dyslipidemic investigational drug candidate CaPre on C-reactive protein (CRP) levels, a biomarker of CardioVascular Disease risk (CVD) and associated with diabetes and obesity.

3 Sep 2010

Halozyme initiates Ultrafast Insulin combination Phase 2 studies with rHuPH20

Halozyme Therapeutics, Inc. today announced the initiation of two Phase 2 Ultrafast Insulin treatment studies that utilize its rHuPH20 hyaluronidase enzyme (PH20) in combination with the two leading commercially available mealtime analogs: insulin aspart, the active ingredient in NovoLog®, and insulin lispro, the active ingredient in Humalog®.

2 Sep 2010

International consortium publishes third-generation map of human genetic variation

An international consortium today published a third-generation map of human genetic variation, called the HapMap, which includes data from an additional seven global populations, increasing the total number to 11 populations. The improved resolution will help researchers interpret current genome studies aimed at finding common and rarer genetic variants associated with complex diseases.

2 Sep 2010

Orexigen and Takeda partner to develop, commercialize Contrave in US, Canada and Mexico

Orexigen® Therapeutics, Inc. and Takeda Pharmaceutical Company Limited, today announced that they have entered into an exclusive partnership to develop and commercialize Contrave® (naltrexone SR/bupropion SR), Orexigen's investigational drug for the treatment of obesity, in the United States, Canada and Mexico.

2 Sep 2010

Agent Orange cases expanded; Added costs raise fiscal concerns

Hundreds of thousands of Vietnam War veterans are receiving disability compensation for diseases normally associated with aging - not combat - because of the possibility of a link Agent Orange exposure. The diseases in question range from diabetes, for which 270,000 veterans receive Agent Orange-related checks, to erectile dysfunction.

2 Sep 2010

Diabetes News and Research

Latest Diabetes News and Research

Study establishes critical roles for cancer-causing Myc gene in stem cell biology

ASIPP announces educational campaign to improve chronic pain patients’ quality of life

Two scientists behind suit to block stem-cell research funding speak with lawmakers

Fresh Market's 16th Annual Sidewalk Sale to benefit Juvenile Diabetes Research Foundation

Research finds role of hormone-secreting fat cells in certain diseases

PCOS Challenge creates television series to help women with Polycystic Ovarian Syndrome

Study reveals factors linked to cognitive impairment in Type 2 diabetes

Discovery of omega-3 fatty acid molecular mechanism paves way for development of dietary remedy for diabetes

European Commission approves MSD's MAA for SYCREST in manic episodes associated with bipolar I disorder

Stem Cell Assurance announces $1M agreement with private funding source

Researchers find hair cortisol level can assess chronic stress in heart attack

NSU receives grant to improve geriatrics care

Researchers unveil prototype model of first implantable artificial kidney

Diabetes drug metformin exhibits potential against tobacco-induced lung tumors

Greater Cincinnati receives award to improve health care system

CaPre drug candidate shows promising result on CRP level reduction

Halozyme initiates Ultrafast Insulin combination Phase 2 studies with rHuPH20

International consortium publishes third-generation map of human genetic variation

Orexigen and Takeda partner to develop, commercialize Contrave in US, Canada and Mexico

Agent Orange cases expanded; Added costs raise fiscal concerns

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Diabetes News and Research

Latest Diabetes News and Research

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in